Decatur Capital Management’s St Jude Medical STJ Stock Holding History

Decatur Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-206,355	Closed	-$12.7M	–	108
2015 Q4	$12.7M	Sell	206,355 -1,150	-0.6%	-$72.5K	1.64%	35
2015 Q3	$13.1M	Sell	207,505 -5,200	-2%	-$371K	1.79%	25
2015 Q2	$15.5M	Buy	212,705 +9,025	+4%	+$652K	1.93%	18
2015 Q1	$13.3M	Buy	203,680 +10,400	+5%	+$692K	1.65%	33
2014 Q4	$12.6M	Sell	193,280 -23,870	-11%	-$1.54M	1.68%	33
2014 Q3	$13.1M	Buy	217,150 +84,400	+64%	+$5.51M	2.19%	16
2014 Q2	$9.19M	Sell	132,750 -59,550	-31%	-$3.86M	1.73%	20
2014 Q1	$12.6M	Sell	192,300 -5,600	-3%	-$365K	2.4%	2
2013 Q4	$12.3M	Sell	197,900 -8,100	-4%	-$469K	2.36%	4
2013 Q3	$11.1M	Buy	206,000 +44,075	+27%	+$2.27M	2.33%	4
2013 Q2	$7.39M	Buy	+161,925	New	+$7.02M	2.56%	9

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Decatur Capital Management's STJ Position: Q1 2016 in Review

Decatur Capital Management sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 206,355 shares — an estimated $12.7M sold.

Decatur Capital Management first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $15.5M in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

Decatur Capital Management reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
Decatur Capital Management sold 206,355 St Jude Medical shares in Q1 2016, an estimated $12.7M.
Decatur Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
Decatur Capital Management's St Jude Medical position peaked at $15.5M in Q2 2015.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Decatur Capital Management's 13F filing for Q1 2016, filed 29 Apr 2016.